Evidence map›Paper›PMID 38514992›Full record

Observational studyESC heart failure2024

Impact of heart rate changes during hospitalization on outcome in heart failure with preserved ejection fraction.

Dan Liu, Xiaotong Cui, Yamei Xu, Lei Xu, Zhonglei Xie, Shuai Yuan, Peng Wang, Yanyan Wang, Sanli Qian, Hui Gong and 5 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Dan LiuDepartment of Cardiology, Internal Medicine I, Comprehensive Heart Failure Center, University Hospital Würzburg, Oberdürrbacher Str. 6, Würzburg, 97080, Germany.
Xiaotong CuiDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.ORCID https://orcid.org/0000-0003-4334-7824
Yamei XuDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Lei XuDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Zhonglei XieDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Shuai YuanDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Peng WangDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Yanyan WangDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Sanli QianDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Hui GongDepartment of Cardiology, Jinshan Hospital of Fudan University, Shanghai, China.
Peter NordbeckDepartment of Cardiology, Internal Medicine I, Comprehensive Heart Failure Center, University Hospital Würzburg, Oberdürrbacher Str. 6, Würzburg, 97080, Germany.ORCID https://orcid.org/0000-0002-2560-4068
Jiefu YangDepartment of Cardiology, Institute of Geriatric Medicine, National Center of Gerontology, Beijing Hospital, Chinese Academy of Medical Sciences, Da Hua Road 1, Dong Dan, Beijing, 100730, China.
Jingmin ZhouDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.
Junbo GeDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.ORCID https://orcid.org/0000-0002-9360-7332
Aijun SunDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Fenglin Road 180, Shanghai, 200032, China.ORCID https://orcid.org/0000-0003-1488-0937
Fudan University · CNComprehensive Cancer Center Mainfranken · DEChinese Academy of Medical Sciences & Peking Union Medical College · CNJinshan Hospital of Fudan University · CN

Funding

National Key R&D Program of the Ministry of Science and Technology of China 2018YFE0103000Sino-German Center for Research Promotion/Chinesisch-Deutsches Zentrum für Wissenschaftsförderung GZ 1659
6 · The paper itself

Abstract

aimsThe benefits of lowering heart rate (HR) in heart failure (HF) with preserved ejection fraction (HFpEF) patients are still a matter of debate. This study aimed to investigate the relationship between changes in HR during hospitalization and cardiovascular (CV) events and all-cause death in hospitalized HFpEF patients. METHODS AND

resultsHospitalized HF patients between January 2017 and December 2021 were consecutively enrolled in a national, multicentred, and prospective registry database, the China Cardiovascular Association Database-HF Center Registry. HF patients with a left ventricular ejection fraction of ≥50% were defined as HFpEF patients. The study analysed admission/discharge HR, change in HR during hospitalization (∆HR), and ∆HR ratio (∆HR/admission HR). The patients were categorized into three groups: no HR dropping group (ΔHR ratio > 0.0%), moderate HR dropping group (-15% < ΔHR ratio ≤ 0.0%), and excessive HR dropping group (ΔHR ratio ≤ -15%). All patients were followed up for 12 months. The primary endpoint was CV events (CV death or HF rehospitalization). The secondary endpoint was all-cause death. A total of 19 510 HFpEF patients (9750 males, mean age 71.9 ± 12.2 years) were included, with 4575 in the no HR dropping group, 8434 in the moderate HR dropping group, and 6501 in the excessive HR dropping group. Excessive HR dropping during hospitalization was significantly associated with an increased risk of CV events (17.1%) compared with the no HR dropping group (14.5%, P < 0.001) or the moderate HR dropping group (14.0%, P < 0.001), although all-cause mortality was similar among the three groups. After adjusting for multiple confounding factors, excessive HR dropping remained an independent predictor of increased CV event risk [hazard ratio 1.197, 95% confidence interval (CI) 1.078-1.328]. Subgroup analysis revealed that the prognostic impact of excessive HR dropping on increased CV event risk remained in the subgroups of older age, New York Heart Association class IV, ischaemic HF, higher left ventricular ejection fraction, absence of chronic kidney disease, and use of beta-blockers or ivabradine. Independent determinants associated with excessive HR dropping during admission included use of beta-blockers [odds ratio (OR) 1.683, 95% CI 1.558-1.819], lower discharge diastolic blood pressure (OR 0.988, 95% CI 0.985-0.991), no pacemaker (OR 0.501, 95% CI 0.416-0.603), coexisting atrial fibrillation or atrial flutter (OR 1.327, 95% CI 1.218-1.445), and use of digoxin (OR 1.340, 95% CI 1.213-1.480).

conclusionsIn hospitalized HFpEF patients, excessive HR dropping during hospitalization is associated with an increased risk of CV death or HF rehospitalization. These findings highlight the importance of HR monitoring and avoiding excessively slowing down HR in hospitalized HFpEF patients to reduce the risk of CV events.

Indexed as

Heart FailureHeart RateHospitalizationRegistriesStroke VolumeVentricular Function, LeftAgedCause of DeathChinaFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisProspective StudiesAdmission heart rateCardiovascularChange in heart rateDischarge heart rateHFpEFRehospitalization

Identifiers

PMID38514992
PMCPMC11424277
OpenAlexW4393076839

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.